KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biocryst Pharmaceuticals (BCRX) Inventory Average (2023 - 2025)

Biocryst Pharmaceuticals (BCRX) has disclosed Inventory Average for 5 consecutive years, with $5.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Inventory Average fell 32.07% year-over-year to $5.3 million, compared with a TTM value of $5.3 million through Dec 2025, down 32.07%, and an annual FY2025 reading of $6.7 million, down 63.33% over the prior year.
  • Inventory Average was $5.3 million for Q4 2025 at Biocryst Pharmaceuticals, up from $5.1 million in the prior quarter.
  • Across five years, Inventory Average topped out at $29.2 million in Q1 2024 and bottomed at $5.1 million in Q3 2025.
  • Average Inventory Average over 3 years is $15.3 million, with a median of $7.8 million recorded in 2024.
  • The sharpest move saw Inventory Average plummeted 78.8% in 2024, then fell 14.45% in 2025.
  • Year by year, Inventory Average stood at $29.2 million in 2023, then crashed by 73.16% to $7.8 million in 2024, then plummeted by 32.07% to $5.3 million in 2025.
  • Business Quant data shows Inventory Average for BCRX at $5.3 million in Q4 2025, $5.1 million in Q3 2025, and $6.0 million in Q2 2025.